Exploratory Study of Radium-223 and VEGF-Targeted Therapy in Patients With Metastatic Renal Cell Carcinoma and Bone Mets
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Sorafenib
Related studies linked through entity extraction aliases.
Sequential Melphalan for Use With Hepatic Delivery System Treatment Followed by Sorafenib in Patients With Unresectable HCC
- Status
- WITHDRAWN
- Phase
- PHASE2
Resminostat (YHI-1001) in Combination With Sorafenib in Asian Patients With Advanced Hepatocellular Carcinoma (HCC)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of BBI608 Administrated With Sorafenib in Adult Patients With Advanced Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
A Study of BBI503 in Advanced Solid Tumors, or BBI503/ Sorafenib in Advanced Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Neoadjuvant Chemotherapy Followed by Radiation Therapy and Gemcitabine/Sorafenib/Vorinostat in Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety of Bevacizumab Plus Sorafenib for the Third-line Treatment in Metastatic Renal Cancer Patients
- Status
- UNKNOWN
- Phase
- PHASE2
Safety and Efficacy Study of CC-122 Combined With Sorafenib for Primary Liver Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Efficacy and Safety of Concurrent TACE and Sorafenib in Patients With HCC and Extrahepatic Metastasis (COTSOM Study)
- Status
- UNKNOWN
- Phase
- PHASE2
Sorafenib and Cyclophosphamide/Topotecan in Patients With Relapsed and Refractory Neuroblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Trametinib in Combination With Sorafenib in Patients With Advanced Hepatocellular Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Sorafenib Concurrent With Yttrium-90 Transarterial Radioembolization in Patients With Advanced Hepatocellular Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
A Study of BBI608 in Combination With Sorafenib, or BBI503 in Combination With Sorafenib in Adult Patients With Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Crenolanib in Combination With Sorafenib in Patients With Refractory or Relapsed Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
A Study of LY2157299 in Participants With Unresectable Hepatocellular Cancer (HCC)
- Status
- COMPLETED
- Phase
- PHASE1
Phase 1b/2 Study of Oprozomib in Combination With Sorafenib in Subjects With Advanced Hepatocellular Carcinoma
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
The Efficacy and Safety of Retreatment With TAI for Patients Who Showed TACE-resistant: a Randomized Controlled Trial
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Sorafenib Plus 5-Azacitidine Initial Therapy of Patients With Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MS) With FLT3-ITD Mutation
- Status
- COMPLETED
- Phase
- PHASE2
A Study of LY2157299 in Participants With Advanced Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Sorafenib Tosylate With or Without Everolimus in Treating Patients With Advanced, Radioactive Iodine Refractory Hurthle Cell Thyroid Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2